• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化人糖蛋白激素超活性类似物。

Engineering human glycoprotein hormone superactive analogues.

作者信息

Szkudlinski M W, Teh N G, Grossmann M, Tropea J E, Weintraub B D

机构信息

Department of Medicine, University of Maryland School of Medicine, Baltimore 21201, USA.

出版信息

Nat Biotechnol. 1996 Oct;14(10):1257-63. doi: 10.1038/nbt1096-1257.

DOI:10.1038/nbt1096-1257
PMID:9631089
Abstract

We report the generation of superactive analogues of human glycoprotein hormones, with potential applications in thyroid and reproductive disorders. Current biological and structural data were used to rationalize mutagenesis. The 11-20 region in the alpha-subunit with a cluster of lysine residues forms a previously unrecognized domain critical for receptor binding and signal transduction, as well as an important motif in the evolution of glycoprotein hormone activities. The gradual elimination of basic residues in the alpha-subunit coincided with the evolutionary divergence of the hominids from the Old World monkeys. By selective reconstitution of certain critical residues present in homologous nonhuman hormones we have developed human thyroid stimulating hormone and chorionic gonadotropin analogues with substantial increases in receptor binding affinity and bioactivity, thus providing a paradigm for the design of novel therapeutic protein analogues.

摘要

我们报告了人类糖蛋白激素超活性类似物的产生,其在甲状腺和生殖系统疾病方面具有潜在应用价值。利用当前的生物学和结构数据来合理指导诱变。α亚基中含有赖氨酸残基簇的11 - 20区域形成了一个此前未被识别的结构域,该结构域对受体结合和信号转导至关重要,同时也是糖蛋白激素活性进化中的一个重要基序。α亚基中碱性残基的逐渐消除与人类从旧世界猴的进化分歧相吻合。通过选择性重建同源非人类激素中存在的某些关键残基,我们开发出了受体结合亲和力和生物活性大幅提高的人促甲状腺激素和绒毛膜促性腺激素类似物,从而为新型治疗性蛋白质类似物的设计提供了范例。

相似文献

1
Engineering human glycoprotein hormone superactive analogues.工程化人糖蛋白激素超活性类似物。
Nat Biotechnol. 1996 Oct;14(10):1257-63. doi: 10.1038/nbt1096-1257.
2
Chimeric proteins can exceed the sum of their parts: implications for evolution and protein design.嵌合蛋白的功能可能超越其各部分功能之和:对进化和蛋白质设计的启示
Nat Biotechnol. 1997 May;15(5):439-43. doi: 10.1038/nbt0597-439.
3
A single-chain tetradomain glycoprotein hormone analog elicits multiple hormone activities in vivo.一种单链四结构域糖蛋白激素类似物在体内引发多种激素活性。
Biol Reprod. 2005 Feb;72(2):301-8. doi: 10.1095/biolreprod.104.031732. Epub 2004 Sep 22.
4
Structure-based design and protein engineering of intersubunit disulfide bonds in gonadotropins.
Nat Biotechnol. 1997 Jul;15(7):658-62. doi: 10.1038/nbt0797-658.
5
Crystal structure of human chorionic gonadotropin.人绒毛膜促性腺激素的晶体结构
Nature. 1994 Jun 9;369(6480):455-61. doi: 10.1038/369455a0.
6
A rational design strategy for protein hormone superagonists.一种蛋白质激素超级激动剂的合理设计策略。
Nat Biotechnol. 1998 Sep;16(9):871-5. doi: 10.1038/nbt0998-871.
7
Glycosylation is the structural basis for changes in polymorphism and immunoreactivity of pituitary glycoprotein hormones.糖基化是垂体糖蛋白激素多态性和免疫反应性变化的结构基础。
Eur J Clin Chem Clin Biochem. 1996 Sep;34(9):749-53.
8
Molecular architecture and biorecognition processes of the cystine knot protein superfamily: part I. The glycoprotein hormones.胱氨酸结蛋白超家族的分子结构与生物识别过程:第一部分。糖蛋白激素。
J Mol Recognit. 2000 Sep-Oct;13(5):223-78. doi: 10.1002/1099-1352(200009/10)13:5<223::AID-JMR501>3.0.CO;2-L.
9
Hyperexpression and purification of biologically active human luteinizing hormone and human chorionic gonadotropin using the methylotropic yeast, Pichia pastoris.利用甲基营养型酵母毕赤酵母对具有生物活性的人促黄体生成素和人绒毛膜促性腺激素进行超表达和纯化。
Protein Expr Purif. 2003 Dec;32(2):175-84. doi: 10.1016/S1046-5928(03)00231-6.
10
Functional homodimeric glycoprotein hormones: implications for hormone action and evolution.
Chem Biol. 1998 May;5(5):241-54.

引用本文的文献

1
STR mutations on chromosome 15q cause thyrotropin resistance by activating a primate-specific enhancer of MIR7-2/MIR1179.15q 染色体上的 STR 突变通过激活灵长类特有的 MIR7-2/MIR1179 增强子导致促甲状腺素抵抗。
Nat Genet. 2024 May;56(5):877-888. doi: 10.1038/s41588-024-01717-7. Epub 2024 May 7.
2
Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.促甲状腺激素受体(TSHR)作为分化型甲状腺癌成像的靶点。
Surgery. 2024 Jan;175(1):199-206. doi: 10.1016/j.surg.2023.05.045. Epub 2023 Oct 31.
3
Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment.
促胃液素抑制素受体 2 和促甲状腺激素受体在嗜酸细胞性甲状腺肿瘤中的表达:对预后和治疗的影响。
Mod Pathol. 2023 Dec;36(12):100332. doi: 10.1016/j.modpat.2023.100332. Epub 2023 Sep 15.
4
Autoantibody mimicry of hormone action at the thyrotropin receptor.促甲状腺激素受体上激素作用的自身抗体模拟。
Nature. 2022 Sep;609(7928):846-853. doi: 10.1038/s41586-022-05159-1. Epub 2022 Aug 8.
5
In Vivo Imaging of Thyroid Cancer with Tc-TR1401 and Tc-TR1402: A Comparison Study in Dogs.用Tc-TR1401和Tc-TR1402对甲状腺癌进行体内成像:犬类的比较研究
J Clin Med. 2021 Apr 26;10(9):1878. doi: 10.3390/jcm10091878.
6
The Pathogenic TSH β-subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR.致病性 TSHβ亚单位突变 C105Vfs114X 导致 TSHR 信号转导谱发生改变。
Int J Mol Sci. 2019 Nov 7;20(22):5564. doi: 10.3390/ijms20225564.
7
New Frontier in Glycoprotein Hormones and Their Receptors Structure-Function.糖蛋白激素及其受体结构与功能的新前沿
Front Endocrinol (Lausanne). 2015 Oct 19;6:155. doi: 10.3389/fendo.2015.00155. eCollection 2015.
8
(99m)Tc-labeled-rhTSH analogue (TR1401) for imaging poorly differentiated metastatic thyroid cancer.用于成像低分化转移性甲状腺癌的(99m)锝标记重组人促甲状腺素类似物(TR1401)
Thyroid. 2014 Aug;24(8):1297-308. doi: 10.1089/thy.2013.0429. Epub 2014 Jun 20.
9
Thyrotropin isoforms: implications for thyrotropin analysis and clinical practice.促甲状腺激素异构体:对促甲状腺激素分析及临床实践的影响
Thyroid. 2014 Mar;24(3):411-23. doi: 10.1089/thy.2013.0119. Epub 2013 Dec 13.
10
Novel insights on thyroid-stimulating hormone receptor signal transduction.促甲状腺激素受体信号转导的新见解。
Endocr Rev. 2013 Oct;34(5):691-724. doi: 10.1210/er.2012-1072. Epub 2013 May 3.